Intrinsiqs

Is Relay Therapeutics, Inc. overvalued?

Relay Therapeutics, Inc. (RLAY) — key valuation metrics and fundamentals.

No verdict
Price
$18.09
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$4.00B
Dividend yield
0.0%
Return on equity
-40.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RLAY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.